Chalcones and Gastrointestinal Cancers: Experimental Evidence

Int J Mol Sci. 2023 Mar 22;24(6):5964. doi: 10.3390/ijms24065964.

Abstract

Colorectal (CRC) and gastric cancers (GC) are the most common digestive tract cancers with a high incidence rate worldwide. The current treatment including surgery, chemotherapy or radiotherapy has several limitations such as drug toxicity, cancer recurrence or drug resistance and thus it is a great challenge to discover an effective and safe therapy for CRC and GC. In the last decade, numerous phytochemicals and their synthetic analogs have attracted attention due to their anticancer effect and low organ toxicity. Chalcones, plant-derived polyphenols, received marked attention due to their biological activities as well as for relatively easy structural manipulation and synthesis of new chalcone derivatives. In this study, we discuss the mechanisms by which chalcones in both in vitro and in vivo conditions suppress cancer cell proliferation or cancer formation.

Keywords: Helicobacter pylori; angiogenesis; cell death; chalcones; colorectal cancer; gastric cancer; inflammation; multidrug resistance; reactive oxygen species; signaling pathway.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Cell Line, Tumor
  • Chalcones* / chemistry
  • Chalcones* / pharmacology
  • Chalcones* / therapeutic use
  • Gastrointestinal Neoplasms* / drug therapy
  • Humans
  • Neoplasm Recurrence, Local

Substances

  • Chalcones
  • Antineoplastic Agents